Recombinant Anti-CEA x Anti-DR5 Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/07/07
Country: United States
Summary: Recombinant Anti-CEA x Anti-DR5 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can induce targeted apoptosis by activation of the death receptor. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cea%2520%2526%2520dr5.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
